UNBREAKABLE The OC Podcast : Bone Health + Osteoporosis UNBREAKABLE The OC Podcast from Osteoporosis Canada features evidence-based information from healthcare providers and subject matter experts, as well as personal […]

We are aware of a recent Food and Drug Administration (FDA) publication that reports on the association between use of zoledronic acid (Aclasta) and renal impairment. 1 We recognize that […]

UNBREAKABLE The OC Podcast : Bone Health + Osteoporosis UNBREAKABLE The OC Podcast from Osteoporosis Canada features evidence-based information from healthcare providers and subject matter experts, as well as personal […]

No one likes to think about emergency planning but 57% of Canadian adults don’t have a will, and that number goes up to 89% among millennials. Having a solid estate […]

We are aware of recent press reports concerning the link between two drugs for osteoporosis (alendronate and zoledronate) and the occurrence of a heart condition characterized by an irregular heart […]

The Osteoporosis Exemplary Care Program (OECP) at St. Michael’s Hospital in Toronto, Ontario has been a leader in the FLS movement in Canada and worldwide. OECP was founded in 2002 […]

Accessibility Accessibility Accessibility for Ontarians With Disabilities Act (AODA) Accessibility for Ontarians With Disabilities Act (AODA) Osteoporosis Canada is committed to excellence in servicing all customers including people with disabilities. […]

Osteoporosis is a disease that takes years to develop without any warning symptoms. Bone mass is gradually lost, making the bones weaker and more prone to fracturing or breaking. The […]

UNBREAKABLE The OC Podcast : Bone Health + Osteoporosis UNBREAKABLE The OC Podcast from Osteoporosis Canada features evidence-based information from healthcare providers and subject matter experts, as well as personal […]